Compare ATAI & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATAI | NOTE |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 27.5M |
| IPO Year | 2021 | N/A |
| Metric | ATAI | NOTE |
|---|---|---|
| Price | $4.19 | $1.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $14.33 | ★ $29.25 |
| AVG Volume (30 Days) | ★ 3.2M | 238.1K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,018,000.00 | ★ $102,673,000.00 |
| Revenue This Year | $943.18 | N/A |
| Revenue Next Year | N/A | $0.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 811.78 | N/A |
| 52 Week Low | $1.15 | $1.60 |
| 52 Week High | $6.75 | $24.36 |
| Indicator | ATAI | NOTE |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 31.04 |
| Support Level | $3.88 | $1.63 |
| Resistance Level | $4.72 | $1.94 |
| Average True Range (ATR) | 0.25 | 0.15 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 35.71 | 12.73 |
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.